𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Apoptosis in breast cancer and its relationship to clinicopathological characteristics and prognosis

✍ Scribed by Nishimura, Reiki; Nagao, Kazuharu; Miyayama, Haruhiko; Matsuda, Masakazu; Baba, Kenichirou; Matsuoka, Yukio; Yamashita, Hiroya; Fukuda, Makoto; Higuchi, Akihiro


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
396 KB
Volume
71
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis


Background and Objectives: Apoptosis is essential to maintain homeostasis in living organisms and occurs in a variety of tissues in response to both physiological and pathological stimuli. In breast cancer, most cytotoxic drugs and hormonal treatments induce apoptosis. We studied the relationships between apoptosis and clinicopathological variables or prognosis in 143 patients with operable breast cancer. Methods: Apoptosis was numerically graded in 5 consecutive 40Γ— highpower fields (HPF) of hematoxylin-eosin (H&E) stained sections, since we showed that there was a significant correlation of H&E staining with terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) staining.

Results:

The average number of apoptotic cells was 19.9 (0∼168)/5 HPF, and cases were classified into 3 groups based on the number of apoptotic cells/5HPF: 0 to 10, 11 to 30, and 31+. The level of apoptosis increased with increasing size of the tumor, and apoptosis was rarely seen in tumors with positive ER or lower proliferative activity, as assessed by DNA polymerase ␣. As shown by DNA content analysis, apoptotic cells were observed more frequently in tumors with low G1 and high S-phase fractions. In addition, apoptosis was correlated with overexpression of p53 and poor prognosis. Although apoptosis did not correlate with EIC (extensive intraductal component) status, tumors with comedo component had higher values of apoptosis than those without comedo component. Conclusions: In breast cancer, apoptosis might reflect biological behavior, namely a higher degree of biological aggressiveness and unfavorable prognosis.


πŸ“œ SIMILAR VOLUMES


p53 protein expression in pancreatic tum
✍ Aizawa, Shunji; Sasaki, Mutsuo; Wada, Ryu Ichi; Koyama, Motoi; Yagihashi, Soroku πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 523 KB

We examined the expression of p53 protein by immunohistochemical method in a series of pancreatic tumors and evaluated its relationships to the clinicopathological factors and prognosis. The study involved 108 cases of pancreatic tumors (79 ductal carcinomas, 1 acinar cell carcinoma, 14 endocrine tu

Relationship between p53 gene abnormalit
✍ Ram Seshadri; Anthony S.-Y. Leong; Kieran McCaul; Frank A. Firgaira; Vittal Setl πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 757 KB

The prognostic significance of p53 gene abnormalities was investigated in 9 I9 primary breast-cancer patients. p53 expression and tumour-cell proliferation fraction determined by MIB-I count, p53 exon 5 and 6 mutations and HER-Z/neu oncogene amplification were detected by immunohistochemistry, PCR-S

Plasma prolactin and its relationship to
✍ H. G. Kwa; F. Cleton; M. De Jong-Bakker; R. D. Bulbrook; D. Y. Wang; J. L. Haywa πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 French βš– 460 KB

## Abstract The prolactin concentration has been determined in plasma from ostensibly healthy women living on the Island of Guernsey. There were 102, 42 and 41 women who had a mother, sister or maternal aunt, respectively, with breast cancer. The remaining 184 women in this study claimed to have no